Esorol 40 is a proton pump inhibitor (PPI) formulation containing Esomeprazole Sodium 40 mg, intended for intravenous administration. It is used for the short-term treatment of acid-related gastrointestinal conditions, particularly when oral administration is not feasible.
Key Features:
Each vial contains Esomeprazole Sodium equivalent to 40 mg of Esomeprazole.
Provides rapid acid suppression and symptom relief.
Sterile lyophilized powder for reconstitution and IV use.
Ideal for hospital settings where fast and effective acid control is required.
Indications:
Gastroesophageal Reflux Disease (GERD) with erosive esophagitis
Peptic Ulcer Disease
Prevention of rebleeding in gastric or duodenal ulcers
Zollinger-Ellison Syndrome and other hypersecretory conditions
Prophylaxis of stress ulcers in critically ill patients
Dosage & Administration:
Administered intravenously for 10 to 30 minutes.
Dosage should be determined by the physician based on the severity of the condition.
Suitable for once-daily administration, or as prescribed.
Benefits:
Rapid onset of action in controlling gastric acid secretion.
Effective alternative when oral therapy is not suitable.
Reduces gastric acid-related complications in hospitalized patients.
Storage:
Store below 25°C, protected from light and moisture.
Reconstituted solution should be used immediately or as directed.
